Knowledge

Antiserum

Source đź“ť

571:. The use of antiserum is particularly effective against pathogens which are capable of evading the immune system in their unstimulated state but are not robust enough to evade the stimulated immune system. The existence of antibodies to the agent depends on an initial survivor whose immune system, by chance, discovered a counteragent to the pathogen or a host species which carries the pathogen but does not experience its effects. Further stocks of antiserum can then be produced from the initial donor or from a donor organism that is inoculated with the pathogen and cured by some stock of pre-existing antiserum. Diluted snake venom is often used as an antiserum to give passive immunity to snake venom itself. 231: 521:, reliable treatment options had not yet been found or approved. In reaction, convalescent blood plasma was considered as a possibility and is used as a treatment option at least for severe cases. In May 2021, India was one of the first major country to remove plasma from its national COVID-19 guidelines. This was after public criticism of the lack of plasma's effectiveness, criticism of health systems, and persuasion by leading Indian scientists including Shahid Jameel, 219:, they had three to four weeks to recover in a quarantine facility, where data on them was recorded. They had to be in perfect medical condition for the immunization, and the quarantine facility ensured that they were free of microbes which could infect the other horses. In the Behring facilities, the horses were viewed as life savers; therefore, they were well treated. A few of the individual horses used for serum production were 32: 400:, the first humanized monoclonal antibody was approved in its place. Monoclonal antibodies became advantageous due to their decreased variability in quality, a decreased risk of bloodborne diseases, and increased potency. This enabled a large expansion of the usages of antiserum and opened the door for the treatment of autoimmune diseases. 214:
Horses were transported from Poland or Hungary to the Behring facilities in Marburg, in the west-central part of Germany. Most of the horses were transported by rail and treated like any other freight load. During the interminable border crossing, horses were left at the mercy of the weather. Once
210:
countries, mostly Hungary and Poland. Because of Behring's limited financial resources, most horses he selected had been intended for slaughter; however, the usefulness of the animal to others had no influence on the production of serum. Serum horses were calm, well-mannered, and in good health.
574:
Horses that were infected by a pathogen were vaccinated thrice in increasing sizes of the dose. The time between each vaccination varied from each horse and its health condition. Normally the horses needed a few weeks to produce the serum in the blood after the last vaccination. Even though they
194:
It was necessary for Behring to immunize larger animals in order to produce enough serum to protect humans, because the amount of antiserum produced by guinea pigs was too little to be practical. Horses proved to be the best serum producer, as the serum of other large animals is not concentrated
597:
In order to find the moment when most antitoxins in the blood cells of the horses is produced, frequent blood samples were taken from the horses. At the point when the highest amount of antibodies were produced, five liters of blood, a tenth of the blood volume of a horse, were taken through a
1108:
de Andrade, Fábio Goulart; Eto, Silas Fernandes; Navarro dos Santos Ferraro, Ana Carolina; Gonzales Marioto, Denise Turini; Vieira, Narciso Júnior; Cheirubim, Ana Paula; de Paula Ramos, Solange; Venâncio, Emerson José (May 2013). "The production and characterization of anti-bothropic and
593:
The horse was immunized with all types of snake poison at the same time because it was not always possible to know by which snake species a person had been bitten. Therefore, the serum had to immunize the subject against the venom of every snake species.
396:(RSV) for high-risk newborns. This was considered a breakthrough, as the clinical trial was proven to reduce infant hospitalizations by 41% and length of hospital stays by 53%. After two years the product demand began to exceed the supply of plasma and 494:
Humanized monoclonal antibodies are identified with the suffix "-zumab". They mostly originate from a human but differ in the component that attaches to its target. An example of a humanized monoclonal antibody is
411:) are treated, with 30 drugs—28 of which for chronic conditions—with monoclonal antibodies being approved. Monoclonal antibodies are currently being researched to treat viral diseases without vaccines, such as 611:
After the blood sampling, the horses could rest for three to four weeks and received extra food to recover the blood loss. In this period the horses were especially weak and prone to disease and infection.
164:, describes the treatment of infectious disease using the serum of animals that have been immunized against the specific organisms or their product, to which the disease is supposedly referable. 483:
Chimeric monoclonal antibodies are identified with the suffix "-ximab". They originate partially from a murine animal and partially from a human. An example of a chimeric monoclonal antibody is
249:
saved the life of a young girl with diphtheria by injecting antiserum for the first time in history. Serum horses proved to be saviors of diphtheria-infected people. Subsequently, treatment of
52:
Dives too deep into monoclonal, which mostly isn’t produced by live humans (or domestic animals) donating their serum, even in "modern use"! Antiserum needs to be serum or derived from it.
1256:
Vogel, Carl-Wilhelm; Finnegan, Paul W.; Fritzinger, David C. (October 2014). "Humanized cobra venom factor: Structure, activity, and therapeutic efficacy in preclinical disease models".
206:, a large number of horses were needed for military purposes. It was difficult for Behring to find enough German horses for his serum facility. He chose to obtain horses from 608:
Concentration and sterility of the serum were checked carefully, and the serum was filtered many times. Protein content was decreased in order to use the serum for humans.
1025: 1326: 867: 385:. Another breakthrough occurred in 2003. A new technology allowed for heavy and light chain immunoglobulin genes to be amplified from human B cells and cloned into 245:
At the end of the 19th century, every second child in Germany was infected with diphtheria, the most frequent cause of death in children up to 15 years. In 1891
704: 930: 526: 326:
in the 1940s diminished interest in treating bacterial infections with antiserum, but its use for viral infections continued with the development of
906: 1001: 389:. In 2008, this method was refined with a greater ability to sort cells and clone, which led to the discovery of more human monoclonal antibodies. 1144:
Mortimer, Nathan T.; Goecks, Jeremy; Kacsoh, Balint Z.; Mobley, James A.; Bowersock, Gregory J.; Taylor, James; Schlenke, Todd A. (2013-06-04).
956: 575:
tried to empower the immune system of the horses during this immunization with painstaking care, most of the horses experienced appetite loss,
506:
Human monoclonal antibodies are identified with the suffix "-umab". They originate from a human. An example of a human monoclonal antibody is
183:
Behring had pioneered the technique, using guinea pigs to produce serum. Based on his observation that people who survived infection with the
1319: 1211:
O'Leary, M.A.; Maduwage, K.; Isbister, G.K. (May 2013). "Use of immunoturbidimetry to detect venom–antivenom binding using snake venoms".
1043: 977: 432: 1062: 1312: 868:"Paul-Ehrlich-Institut - Press Releases - Paul-Ehrlich-Institut Approves First COVID-19 Therapy Study with Convalescent Plasma" 265: 605:
formation which contained the red blood cells, the serum was visible. The color of the serum varied from milky to brown.
727: 74: 446:
conditions. Acute conditions may include, but are not limited to Ebola virus, envenomation (e. g. snake bites), and
275:
Serum therapy became increasingly prevalent for infectious diseases, and was even used to treat patients during the
601:
The blood was collected in a glass cylinder and brought to the laboratory in the Behring facilities. Above the
640:
Mupapa, K; Massamba, M; Kibadi, K; Kuvula, K; Bwaka, A; Kipasa, M; Colebunders, R; Muyembe-Tamfum, JJ (1999).
529:, and others. The World Health Organization recommended against use of plasma in COVID-19 in December 2021. 477: 1372: 393: 230: 184: 261:
developed, and proactive protective vaccination against diphtheria and other microbial diseases began.
1354: 56: 465:
There are four main types of monoclonal antibodies. They are murine, chimeric, humanized, and human.
47: 472:
animals and can trigger allergic reactions in humans. An example of a murine monoclonal antibody is
1298: 678: 1362: 809: 1146:"Parasitoid wasp venom SERCA regulates Drosophila calcium levels and inhibits cellular immunity" 957:"COVID: Public Health Experts Pen Concerns About Plasma to PSA VijayRaghavan – The Wire Science" 745:"History of Passive Antibody Administration for Prevention and Treatment of Infectious Diseases" 392:
In 1996, the FDA approved the use of RSV-IGIV (Respigam), a polyclonal antibody drug to inhibit
370: 177: 1478: 1452: 1377: 1367: 1026:"Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19" 853: 835: 619:
formation of the blood sample was placed back into the animal's body. This procedure is called
544: 351: 292: 19:
This article is about the applications of antiserum. For an explanation of its production, see
1345: 533: 403:
The past 30 years have seen the transformation of how chronic and autoimmune diseases (e. g.
108: 20: 931:"Plasma therapy for Covid 'irrational, non-scientific', change guidelines, experts ask govt" 1157: 451: 382: 300: 220: 590:
The highest immunization risk for horses was the production of antiserum for snake venom.
8: 1409: 642:"Treatment of Ebola Hemorrhagic Fever with Blood Transfusions from Convalescent Patients" 584: 580: 500: 468:
Murine monoclonal antibodies are identified with the suffix "-omab". They originate from
374: 234: 224: 104: 1304: 1161: 191:, which prevents survivors of infections from being infected again with the same agent. 1193: 1180: 1145: 1107: 777: 744: 522: 455: 408: 276: 1273: 1238: 1185: 1126: 1090: 1082: 782: 764: 723: 659: 518: 443: 386: 331: 238: 128: 42: 1294: 366: 1265: 1228: 1220: 1197: 1175: 1165: 1118: 1074: 772: 756: 649: 439: 246: 112: 1122: 131:
from a previous human survivor, used to be the only known effective treatment for
1269: 760: 568: 355: 187:
never became infected again, he discovered that the body continually produces an
1224: 373:
won a Nobel Prize for their paper that described their method for making murine
1473: 620: 207: 120: 116: 567:
then recognizes foreign agents bound to antibodies and triggers a more robust
1467: 1437: 1086: 768: 564: 496: 488: 296: 1170: 1417: 1336: 1277: 1242: 1233: 1189: 1130: 1094: 786: 473: 327: 304: 288: 173: 151: 663: 1447: 1442: 1422: 1002:"WHO recommends against the use of convalescent plasma to treat COVID-19" 507: 397: 343: 323: 258: 203: 96: 810:"Antibody therapeutics approved or in regulatory review in the EU or US" 1432: 1078: 540: 484: 335: 330:
of blood plasma (which allowed for purified antibodies), discovered by
269: 100: 88: 1109:
anti-crotalic IgY antibodies in laying hens: A long term experiment".
1427: 1395: 615:
Within a few years, with experience and observation of the horses, a
548: 547:
drug to be introduced into markets almost 20 years after approval of
511: 359: 279:. Its uses were then quickly expanded to also treat diseases such as 188: 147: 143: 135:
infection with a high success rate of 7 out of 8 patients surviving.
978:"Plasma Dropped from COVID Guidelines: What About HCQ, Ivermectin?" 654: 641: 616: 602: 316: 308: 196: 139: 450:
infection. Chronic conditions may include, but are not limited to
16:
Blood serum containing antibodies; used to spread passive immunity
881: 705:"Serum therapy, especially in its application against diphtheria" 560: 447: 339: 284: 250: 216: 469: 404: 378: 347: 254: 223:, and celebrated for their service to medicine, both human and 142:
laboratories. The most common use of antiserum in humans is as
576: 459: 312: 280: 132: 1210: 420: 416: 1143: 882:"Convalescent Plasma COVID-19 Emergency Use Authorization" 639: 1334: 559:
Antibodies in the antiserum bind the infectious agent or
412: 886:
Convalescent Plasma COVID-19 Emergency Use Authorization
1255: 431:
For a more complete list of monoclonal antibodies, see
1044:"FDA Grants Accelerated Approval for Alzheimer's Drug" 1213:
Journal of Pharmacological and Toxicological Methods
743:Graham, Barney S.; Ambrosino, Donna M. (May 2015). 907:"Call off plasma therapy for patients of covid-19" 334:. Antisera were developed to prevent and/or treat 195:enough, and horses were not believed to carry any 1061:Lo, Daphne; Grossberg, George T. (October 2011). 1465: 1063:"Use of memantine for the treatment of dementia" 842:. National Institute for Cellular Biotechnology. 679:"Emil von Behring: The Founder of Serum Therapy" 536:) were developed for the treatment of COVID-19. 1150:Proceedings of the National Academy of Sciences 804: 802: 800: 798: 796: 742: 311:were proteins that targeted the capsule of the 211:Age, breed, height, and color were irrelevant. 180:published their first paper on serum therapy. 1320: 840:National Institute for Cellular Biotechnology 438:Monoclonal antibodies are used to treat both 237:collected at a blood donor center during the 793: 197:diseases that could be transferred to humans 1060: 1327: 1313: 854:"COVID-19 Convalescent Plasma Transfusion" 1297:at the U.S. National Library of Medicine 1232: 1179: 1169: 776: 653: 433:list of therapeutic monoclonal antibodies 75:Learn how and when to remove this message 975: 904: 829: 827: 825: 823: 229: 362:. However, these were not widely used. 138:Antisera are widely used in diagnostic 1466: 833: 1308: 820: 717: 676: 25: 722:. Stuttgart: Thienemann-Esslinger. 13: 1067:Expert Review of Neurotherapeutics 646:The Journal of Infectious Diseases 539:On June 7, 2021, the FDA approved 14: 1490: 1335:Immune sera and immunoglobulins ( 1288: 954: 836:"What is a Monoclonal Antibody?" 30: 1249: 1204: 1137: 1101: 1054: 1036: 1018: 994: 976:Buckshee, Devina (2021-05-18). 969: 948: 923: 898: 874: 749:Current Opinion in HIV and AIDS 554: 517:During the early stages of the 264:In 1901, Behring won the first 860: 846: 834:Miller, Justine (2016-08-08). 736: 711: 697: 670: 648:. 179 Suppl 1 (179): S18–S23. 633: 1: 1123:10.1016/j.toxicon.2013.01.018 626: 426: 268:for his work in the study of 1270:10.1016/j.molimm.2014.06.035 761:10.1097/COH.0000000000000154 478:acute lymphoblastic leukemia 7: 1373:Hepatitis B immune globulin 1225:10.1016/j.vascn.2013.02.004 394:respiratory syncytial virus 50:. The specific problem is: 10: 1495: 430: 277:influenza pandemic in 1918 167: 18: 1408: 1386: 1353: 1344: 487:, which is used to treat 476:, which is used to treat 111:) that is used to spread 1299:Medical Subject Headings 1363:Anthrax immune globulin 1171:10.1073/pnas.1222351110 905:Livemint (2021-05-11). 532:Monoclonal antibodies ( 293:Haemophilus influenza B 266:Nobel Prize in Medicine 1453:Tixagevimab/cilgavimab 1378:Zoster-immune globulin 1368:Rho(D) immune globulin 718:Kautz, Gisela (2004). 352:varicella zoster virus 242: 215:the horses arrived in 1410:Monoclonal antibodies 1346:Polyclonal antibodies 685:. Nobel Media AB 2021 677:Grundmann, Kornelia. 579:, and in worse cases 534:casirivimab/imdevimab 375:monoclonal antibodies 328:ethanol fractionation 233: 115:to many diseases via 21:polyclonal antibodies 1258:Molecular Immunology 814:The Antibody Society 452:rheumatoid arthritis 301:Michael Heidelberger 185:diphtheria bacterium 178:Kitasato ShibasaburĹŤ 57:improve this article 46:to meet Knowledge's 1162:2013PNAS..110.9427M 501:sickle cell disease 235:Convalescent plasma 127:, passive antibody 1079:10.1586/ern.11.132 720:Die Stute Namenlos 525:, Gagandeep Kang, 523:Soumyadeep Bhaumik 456:ulcerative colitis 409:ulcerative colitis 387:expression vectors 243: 125:convalescent serum 1461: 1460: 1404: 1403: 1156:(23): 9427–9432. 1073:(10): 1359–1370. 955:Staff, The Wire. 543:, the first anti- 519:COVID-19 pandemic 377:by immortalizing 322:The discovery of 239:COVID-19 pandemic 85: 84: 77: 48:quality standards 39:This article may 1486: 1351: 1350: 1329: 1322: 1315: 1306: 1305: 1282: 1281: 1253: 1247: 1246: 1236: 1208: 1202: 1201: 1183: 1173: 1141: 1135: 1134: 1105: 1099: 1098: 1058: 1052: 1051: 1040: 1034: 1033: 1022: 1016: 1015: 1013: 1012: 998: 992: 991: 989: 988: 973: 967: 966: 964: 963: 952: 946: 945: 943: 942: 927: 921: 920: 918: 917: 902: 896: 895: 893: 892: 878: 872: 871: 864: 858: 857: 850: 844: 843: 831: 818: 817: 816:. Scicomvisuals. 806: 791: 790: 780: 740: 734: 733: 715: 709: 708: 701: 695: 694: 692: 690: 674: 668: 667: 657: 637: 527:Soumitra Pathare 299:. In the 1920s, 208:Eastern European 160:, also known as 123:). For example, 113:passive immunity 80: 73: 69: 66: 60: 34: 33: 26: 1494: 1493: 1489: 1488: 1487: 1485: 1484: 1483: 1464: 1463: 1462: 1457: 1400: 1382: 1340: 1333: 1291: 1286: 1285: 1254: 1250: 1234:1959.13/1045701 1209: 1205: 1142: 1138: 1106: 1102: 1059: 1055: 1042: 1041: 1037: 1024: 1023: 1019: 1010: 1008: 1000: 999: 995: 986: 984: 974: 970: 961: 959: 953: 949: 940: 938: 929: 928: 924: 915: 913: 903: 899: 890: 888: 880: 879: 875: 866: 865: 861: 856:. 8 April 2020. 852: 851: 847: 832: 821: 808: 807: 794: 741: 737: 730: 716: 712: 703: 702: 698: 688: 686: 675: 671: 638: 634: 629: 569:immune response 557: 510:, which treats 499:, which treats 436: 429: 356:cytomegalovirus 204:First World War 170: 81: 70: 64: 61: 54: 35: 31: 24: 17: 12: 11: 5: 1492: 1482: 1481: 1476: 1459: 1458: 1456: 1455: 1450: 1445: 1440: 1435: 1430: 1425: 1420: 1414: 1412: 1406: 1405: 1402: 1401: 1399: 1398: 1392: 1390: 1384: 1383: 1381: 1380: 1375: 1370: 1365: 1359: 1357: 1348: 1342: 1341: 1332: 1331: 1324: 1317: 1309: 1303: 1302: 1290: 1289:External links 1287: 1284: 1283: 1264:(2): 191–203. 1248: 1219:(3): 177–181. 1203: 1136: 1100: 1053: 1035: 1017: 993: 968: 947: 922: 897: 873: 859: 845: 819: 792: 755:(3): 129–134. 735: 729:978-3522176446 728: 710: 696: 683:NobelPrize.org 669: 655:10.1086/514298 631: 630: 628: 625: 621:plasmapheresis 556: 553: 428: 425: 169: 166: 121:plasmapheresis 117:blood donation 83: 82: 38: 36: 29: 15: 9: 6: 4: 3: 2: 1491: 1480: 1479:Immune system 1477: 1475: 1472: 1471: 1469: 1454: 1451: 1449: 1446: 1444: 1441: 1439: 1438:Obiltoxaximab 1436: 1434: 1431: 1429: 1426: 1424: 1421: 1419: 1416: 1415: 1413: 1411: 1407: 1397: 1394: 1393: 1391: 1389: 1385: 1379: 1376: 1374: 1371: 1369: 1366: 1364: 1361: 1360: 1358: 1356: 1352: 1349: 1347: 1343: 1338: 1330: 1325: 1323: 1318: 1316: 1311: 1310: 1307: 1300: 1296: 1293: 1292: 1279: 1275: 1271: 1267: 1263: 1259: 1252: 1244: 1240: 1235: 1230: 1226: 1222: 1218: 1214: 1207: 1199: 1195: 1191: 1187: 1182: 1177: 1172: 1167: 1163: 1159: 1155: 1151: 1147: 1140: 1132: 1128: 1124: 1120: 1116: 1112: 1104: 1096: 1092: 1088: 1084: 1080: 1076: 1072: 1068: 1064: 1057: 1050:. 2021-06-07. 1049: 1045: 1039: 1032:. 2020-11-23. 1031: 1027: 1021: 1007: 1003: 997: 983: 979: 972: 958: 951: 936: 932: 926: 912: 908: 901: 887: 883: 877: 869: 863: 855: 849: 841: 837: 830: 828: 826: 824: 815: 811: 805: 803: 801: 799: 797: 788: 784: 779: 774: 770: 766: 762: 758: 754: 750: 746: 739: 731: 725: 721: 714: 706: 700: 684: 680: 673: 665: 661: 656: 651: 647: 643: 636: 632: 624: 622: 618: 613: 609: 606: 604: 599: 595: 591: 588: 586: 582: 578: 572: 570: 566: 565:immune system 562: 552: 550: 546: 542: 537: 535: 530: 528: 524: 520: 515: 513: 509: 504: 502: 498: 497:crizanlizumab 492: 490: 489:Crohn disease 486: 481: 479: 475: 471: 466: 463: 461: 457: 453: 449: 445: 441: 434: 424: 422: 418: 414: 410: 406: 401: 399: 395: 390: 388: 384: 380: 376: 372: 368: 363: 361: 357: 353: 349: 345: 341: 337: 333: 329: 325: 320: 318: 314: 310: 306: 302: 298: 297:meningococcus 294: 290: 286: 282: 278: 273: 271: 267: 262: 260: 256: 252: 248: 240: 236: 232: 228: 226: 222: 218: 212: 209: 205: 200: 198: 192: 190: 186: 181: 179: 175: 165: 163: 159: 158:Serum therapy 155: 153: 149: 145: 141: 136: 134: 130: 126: 122: 118: 114: 110: 106: 102: 98: 94: 90: 79: 76: 68: 58: 53: 49: 45: 44: 37: 28: 27: 22: 1418:Bezlotoxumab 1387: 1261: 1257: 1251: 1216: 1212: 1206: 1153: 1149: 1139: 1114: 1110: 1103: 1070: 1066: 1056: 1047: 1038: 1029: 1020: 1009:. Retrieved 1005: 996: 985:. Retrieved 981: 971: 960:. Retrieved 950: 939:. Retrieved 937:. 2021-05-10 934: 925: 914:. Retrieved 910: 900: 889:. Retrieved 885: 876: 862: 848: 839: 813: 752: 748: 738: 719: 713: 699: 687:. Retrieved 682: 672: 645: 635: 614: 610: 607: 600: 596: 592: 589: 573: 558: 555:How it works 538: 531: 516: 505: 493: 482: 474:blinatumomab 467: 464: 437: 402: 391: 364: 321: 307:proved that 305:Oswald Avery 289:pneumococcus 274: 263: 247:Emil Behring 244: 213: 201: 193: 182: 174:Emil Behring 171: 161: 157: 156: 152:envenomation 137: 124: 92: 86: 71: 65:January 2023 62: 55:Please help 51: 40: 1448:Raxibacumab 1443:Palivizumab 1423:Motavizumab 1006:www.who.int 545:Alzheimer's 508:ustekinumab 344:Hepatitis B 324:antibiotics 259:snake venom 202:Due to the 162:serotherapy 129:transfusion 99:containing 97:blood serum 59:if you can. 1468:Categories 1433:Nirsevimab 1011:2022-02-04 987:2022-02-04 962:2022-02-04 941:2022-02-04 916:2022-02-04 891:2023-02-20 627:References 541:aducanumab 485:infliximab 427:Modern use 383:hybridomas 336:diphtheria 332:Edwin Cohn 309:antibodies 270:diphtheria 109:polyclonal 105:monoclonal 101:antibodies 89:immunology 1428:Nebacumab 1396:Antivenom 1388:Antiserum 1117:: 18–24. 1087:1744-8360 769:1746-630X 598:cannula. 551:in 2003. 549:memantine 512:psoriasis 365:In 1984, 360:botulinum 225:non-human 189:antitoxin 172:In 1890, 150:to treat 148:antivenom 144:antitoxin 93:antiserum 1295:Antisera 1278:25062833 1243:23416032 1190:23690612 1131:23416799 1095:21955192 982:TheQuint 935:ThePrint 787:25760933 617:rouleaux 603:rouleaux 367:Milstein 317:bacteria 140:virology 103:(either 41:require 1198:8954855 1181:3677475 1158:Bibcode 1111:Toxicon 778:4437582 664:9988160 585:dyspnea 561:antigen 448:anthrax 444:chronic 398:Synagis 379:B cells 340:tetanus 285:measles 251:tetanus 217:Marburg 168:History 43:cleanup 1301:(MeSH) 1276:  1241:  1196:  1188:  1178:  1129:  1093:  1085:  785:  775:  767:  726:  689:8 June 662:  563:. The 470:murine 458:, and 419:, and 405:cancer 371:Köhler 358:, and 348:rabies 295:, and 257:, and 255:rabies 1474:Blood 1194:S2CID 581:shock 577:fever 460:lupus 440:acute 313:virus 281:polio 221:named 133:ebola 95:is a 1355:IVIG 1274:PMID 1239:PMID 1186:PMID 1127:PMID 1091:PMID 1083:ISSN 911:mint 783:PMID 765:ISSN 724:ISBN 691:2021 660:PMID 583:and 442:and 421:MERS 417:SARS 369:and 303:and 176:and 1337:J06 1266:doi 1229:hdl 1221:doi 1176:PMC 1166:doi 1154:110 1119:doi 1075:doi 1048:FDA 1030:FDA 773:PMC 757:doi 650:doi 413:HIV 381:as 315:or 146:or 107:or 87:In 1470:: 1272:. 1262:61 1260:. 1237:. 1227:. 1217:67 1215:. 1192:. 1184:. 1174:. 1164:. 1152:. 1148:. 1125:. 1115:66 1113:. 1089:. 1081:. 1071:11 1069:. 1065:. 1046:. 1028:. 1004:. 980:. 933:. 909:. 884:. 838:. 822:^ 812:. 795:^ 781:. 771:. 763:. 753:10 751:. 747:. 681:. 658:. 644:. 623:. 587:. 514:. 503:. 491:. 480:. 462:. 454:, 423:. 415:, 407:, 354:, 350:, 346:, 342:, 338:, 319:. 291:, 287:, 283:, 272:. 253:, 227:. 199:. 154:. 91:, 1339:) 1328:e 1321:t 1314:v 1280:. 1268:: 1245:. 1231:: 1223:: 1200:. 1168:: 1160:: 1133:. 1121:: 1097:. 1077:: 1014:. 990:. 965:. 944:. 919:. 894:. 870:. 789:. 759:: 732:. 707:. 693:. 666:. 652:: 435:. 241:. 119:( 78:) 72:( 67:) 63:( 23:.

Index

polyclonal antibodies
cleanup
quality standards
improve this article
Learn how and when to remove this message
immunology
blood serum
antibodies
monoclonal
polyclonal
passive immunity
blood donation
plasmapheresis
transfusion
ebola
virology
antitoxin
antivenom
envenomation
Emil Behring
Kitasato ShibasaburĹŤ
diphtheria bacterium
antitoxin
diseases that could be transferred to humans
First World War
Eastern European
Marburg
named
non-human

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑